Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121713233 | 12171323 | 3 | F | 201601 | 20160719 | 20160311 | 20160811 | PER | US-PFIZER INC-2016102007 | PFIZER | 62.00 | YR | F | Y | 0.00000 | 20160811 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121713233 | 12171323 | 1 | PS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | 250 MG, UNK | N | 50711 | 250 | MG | FILM-COATED TABLET | |||||||
121713233 | 12171323 | 2 | SS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | 250 MG, 1X/DAY (250 MG - 6 TABLETS ONE A DAY) | N | M39808 | 50711 | 1500 | MG | FILM-COATED TABLET | QD | |||||
121713233 | 12171323 | 3 | SS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | N | 50711 | FILM-COATED TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121713233 | 12171323 | 1 | Conjunctivitis |
121713233 | 12171323 | 2 | Dry eye |
121713233 | 12171323 | 3 | Ocular hyperaemia |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121713233 | 12171323 | Dry eye | |
121713233 | 12171323 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
121713233 | 12171323 | 2 | 20160121 | 0 |